Premalignant conditions of gastric cancer

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue 6, 2013, Pages 906-911

  Sugano, Kentaro ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

CDX1; CDX2; Gastric cancer; Helicobacter pylori; Intestinal metaplasia; Premalignant condition of the stomach

Indexed keywords

CADHERIN; GLUCAGON; GLUCOSE TRANSPORTER 2; GUANYLATE CYCLASE; GUANYLATE CYCLASE C; HIGH MOBILITY GROUP PROTEIN; MUCIN 2; NITROSAMINE; NOTCH3 RECEPTOR; PROTEIN P16; PROTEIN P53; TESTIS DETERMINING FACTOR; TRANSCRIPTION FACTOR CDX1; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTION FACTOR RUNX3; TRANSCRIPTION FACTOR SOX10; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ACHLORHYDRIA; BACTERIAL GROWTH; BACTERIAL STRAIN; CANCER DIAGNOSIS; CHRONIC GASTRITIS; EPIGENETICS; GASTROINTESTINAL DYSPLASIA; GASTROINTESTINAL ENDOSCOPY; GENE EXPRESSION; GENETIC ANALYSIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; INTESTINE BIOPSY; INTESTINE METAPLASIA; JAPAN; NARROW BAND IMAGING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METHYLATION; REVIEW; RISK FACTOR; STOMACH ADENOCARCINOMA; STOMACH ADENOMA; STOMACH CANCER; STOMACH JUICE; STOMACH MUCOSA; TUMOR XENOGRAFT; METAPLASIA; PATHOLOGY; PRECANCEROUS CONDITIONS; STOMACH; STOMACH NEOPLASMS;

HUMANS; METAPLASIA; PRECANCEROUS CONDITIONS; STOMACH; STOMACH NEOPLASMS;

EID: 84878190666     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12209     Document Type: Review

References (29)

1. Busuttil RA, Boussioutas A. Intestinal metaplasia: a premalignant lesion involved in gastric carcinogenesis. J. Gastroenterol. Hepatol. 2009; 24: 193-201.
2. Malfertheiner P, Megraud F, O'Morain CA etal.; The European Heicobacter Study Group. Management of Helicobacter pylori infection-the Maastricht IV/Florence Consensus Report. Gut 2012; 61: 646-664.
3. Mutoh H, Hakamata Y, Sato K etal. Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice. Biochem. Biophys. Res. Commun. 2002; 294: 470-479.
4. Suh E, Chen I, Taylor J, Traber PG. A homeobox protein related to caudal regulates intestine-specific gene transcription. Mol. Cell. Biol. 1994; 14: 7340-7351.
5. Silberg DG, Furth EE, Taylor JK, Schuck T, Chiou T, Traber PG. CDX1 protein expression in normal, metaplastic and neoplastic human alimentary tract epithelium. Gastroenterology 1997; 113: 478-486.
6. Eda A, Osawa H, Yanaka I etal. Expression of homeobox gene CDX2 precedes that of CDX1 during progression of intestinal metaplasia. J. Gastroenterol. 2002; 37: 94-100.
7. Silberg DG, Sullivan J, Kang E etal. Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology 2012; 122: 689-696.
8. Sakamoto H, Mutoh H, Hayakawa H, Sashikawa M, Sugano K. Cell lineage dynamics in the process leading to intestinal metaplasia. J. Gastroenterol. 2011; 46: 620-628.
9. Mutoh H, Sakurai S, Satoh K etal. Cdx1 induced intestinal metaplasia in the transgenic mouse stomach: comparative study with Cdx2 transgenic mice. Gut 2004; 53: 1416-1423.
10. Mutoh H, Hayakawa H, Sakamoto H, Sashikawa M, Sugano K. Transgenic Cdx2 induces endogenous Cdx1 in intestinal metaplasia of Cdx2-transgenic mouse stomach. FEBS J. 2009; 276: 5821-5831.
11. Mutoh H, Sakurai S, Satoh K etal. Development of gastric carcinoma from intestinal metaplasia in Cdx2-transgenic mice. Cancer Res. 2004; 64: 7740-7747.
12. Tsukamoto T, Mizoshita T, Tatematsu M. Gastric-and-intestinal mixed-type intestinal metaplasia: aberrant expression of transcription factors and stem cell intestinalization. Gastric Cancer 2006; 9: 156-166.
13. Mutoh H, Sashikawa M, Sugano K. Sox2 expression is maintained while gastric phenotype is completely lost in Cdx2-induced intestinal metaplasitic mucosa. Differentiation 2011; 81: 92-98.
14. McDonald SAC, Greaves LC, Gutierrez-Gonzalez L etal. Mechanisms of field cancerization in the huma; n stomach: the expansion and spread of mutated gastric stem cells. Gastroenterology 2008; 134: 500-510.
15. Lu J, Getz G, Miska EA etal. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-838.
16. Kang GH, Shim YH, Jung HY, Kim WH, Ro JY, Rhyu MG. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res. 2001; 61: 2847-2851.
17. Ito K, Chuang LS, Ito T etal. Loss of Runx3 is a key event in inducing precancerous state of the stomach. Gastroenterology 2011; 140: 1536-1546.
18. Guthirrez-Gonzalez L, Graham TA, Rodriguez-Justo M etal. The clonal origins of dysplasia from intestinal metaplasia in the human stomach. Gastroenterology 2011; 140: 1251-1260.
19. Kamada T, Hata J, Sugiu K etal. Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9-year prospective follow-up study in Japan. Aliment. Pharmacol. Ther. 2005; 21: 1121-1126.
20. Take S, Mizuno M, Ishiki K etal. The long-term risk of gastric cancer after the successful eradication of Helicobacter pylori. J. Gastroenterol. 2011; 46: 318-324.
21. Sanduleanu S, Jonkers D, De Bruine A, Hameeteman W, Stockbrugger RW. Double gastric infection with Helicobacter pylori and non-Helicobacter pylori bacteria during acid-suppressive therapy: increase of pro-inflammatory cytokines and development of atrophic gastritis. Aliment. Pharmacol. Ther. 2001; 15: 1163-1175.
22. Kaminishi M, Yamaguchi H, Nomura S etal. Endoscopic classification of chronic gastritis based on a pilot study by the research society for gastritis. Dig. Endosc. 2002; 14: 138-151.
23. Uedo N, Ishihara R, Iishi H etal. A new method of diagnosing gastric intestinal metaplasia: narrow-band imaging with magnifying endoscopy. Endoscopy 2006; 38: 819-824.
24. Osawa H, Yamamoto H, Miura Y etal. Diagnosis of extent of early gastric cancer using flexible spectral imaging color enhancement. World J. Gastrointest. Endosc. 2012; 4: 356-361.
25. Osawa H, Miura Y, Ino Y, Satoh K, Yamamoto H, Sugano K. Blue laser imaging as a new endoscopic system can produce an excellent image of detailed microsctructure and microvasculare in superficial gastroduodenal neoplasm. Gut 2012; 61 (Suppl. 3): A240. (abstract).
26. +-adenosine triphosphatase expression without altering parietal cell number in human gastric mucosa. Gut 2006; 55: 152-157.
27. Barros R, da Costa LT, Pinto-de-Sousa J etal. CDX2 autoregulation in human intestinal metaplasia of the stomach: impact on the stability of the phenotype. Gut 2011; 60: 290-298.
28. Rugge M, Cassaro M, Di Mario F etal. Interdisciplinary group on gastric epithelial dysplasia. Gut 2003; 52: 1111-1116.
29. Tsukuma H, Oshima A, Narahara H, Morii T. Natural history of early gastric cancer: a non-concurrent, long-term, follow-up study. Gut 2000; 47: 618-623.